⌘K

Login Start Free

Home/Filings/4/0001209191-18-045015

4//SEC Filing

Morich Frank 4

Accession 0001209191-18-045015

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 5:09 PM ET

Size

5.3 KB

Accession

0001209191-18-045015

Insider Transaction Report

Form 4

Period: 2018-07-31

Cue Biopharma, Inc.CUE

Director

Transactions

Award
Stock Option (right to buy)
2018-07-31+50,000→ 50,000 total
Exercise: $9.06Exp: 2025-07-31→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]These Stock Options become exercisable in eight equal semi-annual installments beginning January 31, 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0001748615

Filing Metadata

Form type: 4
Filed: Aug 1, 8:00 PM ET
Accepted: Aug 2, 5:09 PM ET
Size: 5.3 KB

View on SEC.gov